PT  - JOURNAL ARTICLE
AU  - Baig, Mirza Amir
AU  - Ansari, Jamil Ahmed
AU  - Ikram, Aamer
AU  - Khan, Mumtaz Ali
AU  - Salman, Muhammad
AU  - Hussain, Zakir
AU  - Baig, Mirza Zeeshan Iqbal
AU  - Chaudhry, Ambreen
AU  - Malik, Muhammad Wasif
AU  - Akram, Khurram Shahzad
AU  - Saeed, Asim
AU  - Ranjha, Muazzam Abbas
AU  - Sultan, Faisal
AU  - Sabir, Sohail
TI  - Prevalence of SARS-CoV-2: An age-stratified, population-based, sero-epidemiological survey in Islamabad, Pakistan
AID  - 10.1101/2021.09.27.21264003
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.27.21264003
4099  - http://medrxiv.org/content/early/2021/09/29/2021.09.27.21264003.short
4100  - http://medrxiv.org/content/early/2021/09/29/2021.09.27.21264003.full
AB  - Introduction Serological surveys are valuable tools to evaluate the extent of disease transmission, measuring preventive effectiveness and proportion of asymptomatic individuals. This age-stratified, serological survey was aimed to measure the COVID-19 distribution and determinants in district Islamabad of Pakistan.Methodology Three-stage cluster sampling, using population proportionate to size technique, starting with a random number was used. A structured, pretested questionnaire was used after taking informed written consent, to gather demographic, risk factor information.Results Seroprevalence was found 16.5% (AR: 16.5%/100,000). The mean age was 35 (±16 Years). The majority were male (64%), self-employed (29%), and had primary level education (33%). The highest seroprevalence was found in the 21-30 years age group (24.8%) while the 41-50 years age group showed the highest attack rate (112.9/100,000 population). The proportion of the population tested that were asymptomatic was 69% (n=711) while the most frequently reported sign/symptom was cough (99%) followed by fever (20%). No known co-morbidity was reported in 86% (n=884) of respondents while hypertension remained the most reported condition (8%). High seroprevalence was observed in urban areas (12.3%) compared to rural union councils (6.4%). Visiting a house where COVID-19 case was isolated (OR 2, CI 1.38-2.84, P< 0.001), history of contact with a known case of COVID-19 (OR 1.42, CI 1.11-1.82, P=0.005), and attending a mass gathering (OR 1.21, CI: 1.02-1.42, p=0.02) were significant risk factors associated with contracting an infection. A Chi-Square test of independence showed significant protection while using regular hand hygiene practices (6.5; p<0.05) and regular usage of face masks (8.6; p<0.05).Conclusion Seroprevalence gives a direct estimation of population groups exposed to the virus. A remarkable difference in prevalence is found in urban and rural areas, extreme age groups, and socioeconomic statuses, suggesting targeted public health interventions. Sero-studies are affordable counterparts of molecular testing where quick estimation, prevention effectiveness, and data-driven public health policies are priorities.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementAuthors declare no financial supportAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:An institutional review board (IRB) approval was obtained from National Institute of Health PakistanAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be available one request from the first author via email